← Anika Therapeutics, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $103.4m |
$113.4m
+9.71%
|
$105.6m
-6.93%
|
$114.6m
+8.58%
|
$130.5m
+13.83%
|
$147.8m
+13.29%
|
$156.2m
+5.71%
|
$166.7m
+6.67%
|
$119.9m
-28.05%
|
$112.8m
-5.91%
|
$120.7m
+6.94%
|
|
| Cost of Revenue | $24.0m |
$27.4m
+13.89%
|
$31.3m
+14.31%
|
$28.7m
-8.10%
|
$61.4m
+113.70%
|
$64.9m
+5.57%
|
$62.7m
-3.38%
|
$63.6m
+1.46%
|
$43.9m
-30.93%
|
$49.0m
+11.62%
|
$45.6m
-6.86%
|
|
| Gross Profit | $79.4m |
$86.1m
+8.45%
|
$74.3m
-13.69%
|
$85.9m
+15.60%
|
$69.0m
-19.61%
|
$82.9m
+20.16%
|
$93.6m
+12.82%
|
$103.1m
+10.16%
|
$76.0m
-26.28%
|
$63.8m
-16.04%
|
$75.0m
+17.55%
|
|
| Research and Development Expense | $10.7m | $18.8m | $18.2m | $16.7m | $23.4m | $27.3m | $28.2m | $32.7m | $25.5m | $25.8m | $27.5m | |
| Selling, General and Administrative Expense | $18.0m | $21.5m | $34.3m | $35.0m | $60.1m | $74.1m | $84.8m | $95.8m | $55.6m | $49.1m | $52.7m | |
| Amortization of Intangible Assets | $1.1m | $1.0m | $1.0m | $1.0m | $7.4m | $7.8m | $7.8m | $7.8m | $700k | $400k | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | $50.6m |
$45.7m
-9.64%
|
$21.7m
-52.44%
|
$34.2m
+57.47%
|
($28.3m)
-182.70%
|
$2.6m
+109.23%
|
($19.4m)
-841.87%
|
($87.6m)
-351.75%
|
($5.1m)
+94.18%
|
($11.1m)
-116.64%
|
($5.1m)
+53.66%
|
|
| Foreign Currency Transaction Gain (Loss), before Tax | ($300k) | $700k | ($400k) | — | $300k | ($400k) | ($500k) | $100k | ($200k) | ($400k) | — | |
| Gain (Loss) on Investments | — | — | $371k | $25k | ($13k) | — | — | — | — | — | — | |
| Interest Income (Expense), Nonoperating, Net | $263k | $473k | $1.5m | $1.9m | ($302k) | ($188k) | $654k | $2.3m | $2.3m | $1.7m | $2.3m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $50.2m | $48.4m | $26.2m | $38.3m | ($25.7m) | ($2.5m) | ($19.1m) | ($86.1m) | ($4.1m) | ($10.2m) | ($2.9m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $50.9m | $46.2m | $23.2m | $36.1m | ($28.6m) | $2.4m | ($18.7m) | ($85.3m) | ($2.8m) | ($9.3m) | ($2.9m) | |
| Current Income Tax Expense (Benefit) | $18.5m | $15.4m | $6.8m | $8.3m | ($1.6m) | $26k | $1.4m | $3.8m | $5.8m | $611k | $208k | |
| Income Tax Expense (Benefit) | $18.3m | $14.4m | $4.5m | $8.9m | ($4.6m) | ($1.7m) | ($3.9m) | ($2.7m) | $6.1m | $672k | $208k | |
| Net Income (Loss) Attributable to Parent | $32.5m |
$31.8m
-2.25%
|
$18.7m
-41.16%
|
$27.2m
+45.25%
|
($24.0m)
-188.19%
|
$4.1m
+117.24%
|
($14.9m)
-459.43%
|
($82.7m)
-456.34%
|
($56.4m)
+31.79%
|
($10.9m)
+80.70%
|
($3.8m)
+65.22%
|
|
| Earnings Per Share, Basic | $2.22 | $2.18 | $1.30 | $1.93 | ($1.69) | $0.29 | ($1.02) | ($5.64) | ($3.83) | ($0.76) | ($0.27) | |
| Earnings Per Share, Diluted | $2.15 | $2.11 | $1.27 | $1.89 | ($1.69) | $0.28 | ($1.02) | ($5.64) | ($3.83) | ($0.76) | ($0.27) | |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | — | — | — | — | — | — | ($1) | ($1) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | — | — | — | — | — | ($1) | ($1) | — | |
| Weighted Average Number of Shares Outstanding, Basic | 14.7m | 14.6m | 14.4m | 14.1m | 14.2m | 14.4m | 14.6m | 14.7m | 14.7m | 14.3m | 13.9m | |
| Weighted Average Number of Shares Outstanding, Diluted | 15.1m | 15.1m | 14.7m | 14.4m | 14.2m | 14.6m | 14.6m | 14.7m | 14.7m | 14.3m | 13.9m | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | $52.8m | $67.7m | $83.8m | $80.4m | $97.3m | $80.3m | $113.0m | $190.7m | $81.1m | $74.9m | — | |
| Goodwill, Impairment Loss | — | — | — | — | $42.5m | $0 | $0 | — | — | — | $65.3m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | — | ($8.8m) | ($10.0m) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | ($901k) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | — | ($47.6m) | ($901k) | — |